anaerobic bioburden in the cystic fibrosis (CF) airways; however, the role of anaerobic bacteria in the pathogenesis of infection and inflammation in the CF airways remains largely 49 underexplored.
51

What This Study Adds to the Field
52
In the current study we demonstrate a high prevalence of anaerobes in the airways of people 53 with CF that increases with age. Short-chain fatty acids (SCFAs) were secreted by anaerobic 54 bacteria in vitro and were also detected in vivo in CF bronchoalveolar lavage. SCFAs induced 55 a significant IL-8 response in bronchial epithelial cells that was more pronounced in CF than 56 normal bronchial epithelium. Receptors for SCFAs, GPR41 and GPR43, were both expressed 57 in bronchial epithelial cells. However, only GPR41 was upregulated in CF compared to 58 normal airway epithelium in vitro and in vivo. GPR41 upregulation was intrinsically driven 59 by the lack of CFTR activity and endoplasmic reticulum stress and further corroborated by 60 inflammatory stimuli. This study provides novel insight into the pathophysiological role of 61 anaerobic bacteria in the CF airways.
63
This article has an online supplement, which is accessible from this issue's table of content 64 online at www.atsjournals.org. GPR43 (FFAR2) and by the inhibition of histone deacetylase (HDAC) (24) (25) (26) .
Introduction
120
In the current study, we investigated the capacity of anaerobic bacteria, found in the CF 121 airways, to induce an inflammatory response by the production of SCFAs. The results reveal 122 that these anaerobes produce copious amounts of SCFAs that were also present in the adults, 60 ml of sterile 0.9% NaCl was instilled into the right or left sub-segmental bronchi. 6 prevent upper airway contamination suction was not performed until the tip of the 156 bronchoscope was past the carina. During the procedure, 1 ml/kg of sterile 0.9% NaCl was 157 instilled twice in the right middle lobe and twice in the lingula and all four samples were 158 pooled. BAL intended for anaerobic bacterial isolation and identification was handled as 159 described for sputum above and BAL samples intended for SCFAs determination were 160 filtered through gauze and centrifuged at 500g for 10 min at 4°C. The microbiological culture 161 and identification of bacteria in sputum and BAL were carried out as described previously 162 (7).
164
Bronchial brushing sample collection. All patients (control subjects and PWCF) were 165 undergoing diagnostic or therapeutic fiber-optic bronchoscopy as part of routine care.
166
Bronchial brushings were recovered as previously described (27). PWCF over 6 years of age (57.7 %, n = 85, mean age 25.6 ± 8.9 years, 54 males and 31 188 females) compared to PWCF under 6 years of age (33.3 %, n = 24, mean age 3.5 ± 1.6 years, 189 11 males and 13 females; Figure 1A) 30.1 ± 9.7 years; 3 males and 7 females) compared to children with CF (n = 6; mean age 4.5 223 ± 1.9 years; 2 males and 4 females; Figure 1D ). A correlation analysis was performed to 224 investigate whether this phenomenon was associated with SCFAs levels in CF BAL. IL-8 225 levels displayed a strong correlation with acetic acid in BAL samples from children and 226 adults with CF (n = 16, r 2 = 0.6409, P = 0.002; Figure 1E ). Similarly, a significant correlation propionic (1 mM) and butyric acid (1 mM; Figure 4D ). Collectively, these data corroborate 291 the involvement of GPR41 in SCFA-mediated IL-8 release by CF bronchial epithelial cells. microscopy ( Figure 5C ), a significant increase in co-localization of the GPR41 receptor with 305 the plasma membrane marker, Na/K-ATPase, was observed in CFBE41o-(11.9 ± 2.0%) 306 compared to 16HBE14o-(6.9 ± 1.1%, P = 0.0434) cells. No differences in GPR43 cell 307 surface expression were detected in 16HBE14o-and CFBE41o-cells when analyzed with 308 laser scanning cytometry or confocal microscopy ( Figure E11 ). These results suggest that 
312
To investigate whether GPR41 mRNA was also increased in CFBE41o-cells, qRT-PCR was 313 performed. GPR41 mRNA levels were significantly increased in CFBE41o-compared to 314 16HBE14o-cells (P < 0.001; Figure 5D ). The in vitro trend was also observed in vivo as an 315 increase in GPR41 mRNA levels in bronchial brushings from PWCF compared to non-CF 316 controls (P = 0.0064; Figure 5E ). Figure E10 ).
326
Tunicamycin and thapsigargin significantly increased GPR41 protein levels in 16HBE14o-327 cells (P = 0.0297 and P = 0.0198, respectively; Figure 6A ) These data suggest that ER stress
328
and UPR may have a role in the GPR41 upregulation in CF bronchial epithelial cells. significantly increased GPR41 mRNA levels in 16HBE14o-cells (P = 0.0166; Figure 6B ) 336 matching them to levels found in CFBE41o-cells ( Figure 5 ). Similarly, 10% CF BAL caused 337 a significant upregulation of GPR41 mRNA in 16HBE14o-cells (P < 0.001; Figure 6B ).
338
These findings were translated to the protein level, as both CFTR(inh)-172 and 10% CF BAL 339 significantly elevated GPR41 protein levels in 16HBE14o-cells (P = 0.0233 and P = 0.0098, 340 respectively; Figure 6C SCFA secretome ( Figure 1B ). SCFAs were also detected in CF BAL and were elevated in
359
BAL samples from adult PWCF compared to children with CF ( Figure 1C ). This suggests 360 that alongside anaerobes, SCFAs also increase with age. Although SCFAs were previously 361 studied in the context of allergic airway inflammation (31), to our knowledge, this is the first 362 report proving the presence of SCFAs in the lower airways.
363
CF airway disease is characterized by an exaggerated neutrophil influx that plays a key role 
414
In conclusion, we propose a novel mechanism by which anaerobic bacteria, through the 415 production of SCFAs, contribute to the inflammatory environment in the CF airways in this 416 way, potentially amplifying mobilization of neutrophils, tissue destruction and disease
417
progression. This data suggests that eradication of anaerobes in PWCF may be beneficial in 418 order to resolve the excessive inflammation brought on by these microorganisms. cultures in children with CF up to 6 years of age (n = 24; mean age 3.5 ± 1.6 years; 11 males 560 and 13 females) and people with CF over the age of 7 (n = 85; mean age 25. quantified by densitometry and normalized against GAPDH that served as loading control.
598
Bar graph depicts densitometric analysis of GPR41 expression. All data are presented as (80 nM) 24 h before treatment with acetic (10 mM), propionic (1 mM) and butyric acid (1 601 mM) for additional 24 h. Cell supernatants were monitored for IL-8 secretion using ELISA.
602
The results shown are representative of three independent experiments. * P ≤ 0.05, ** P ≤ CFBE41o-cells were grown on coverslips and probed with anti-GPR41 and anti-Na/K- and non-CF controls (n = 3, mean age 56.3 ± 9.5 years, 3 females). Expression of GPR41 626 relative to GAPDH was determined using the 2 (-∆∆Ct) method and presented as fold 627 differences. Data are presented as means ± SEM (n ≥ 3). ** P ≤ 0.01, *** P ≤ 0.001. with CFTR(inh)-172 (10 μM) or 10% CF BAL for 24 and 6 h, respectively and the GPR41 637 mRNA levels were evaluated using qRT-PCR as described in materials and methods.
638
Expression of GPR41 relative to GAPDH was determined using the 2 (-∆∆Ct) method and 
